Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conditioning and Health Training in Rheumatoid Arthritis
NL-OMON44827Not yet recruiting
- Sponsor
- Leiden University
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methotrexate and prednisone in rheumatoid arthritis (RA) (3 arms), sponsored by Leiden University. Primary endpoint: Drug-free clinical remission at 12 months. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
methotrexateprednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON44827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44827.